Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards

Aim: The majority of patients hospitalized with COVID-19 are older individuals. Age and the comorbidities typically associated with it usually go hand in hand with a less favorable course of the disease. We were interested in the antibody response in this particular patient group as well as in the r...

Full description

Bibliographic Details
Main Authors: Epstude, Jörg, Skiba, Marcin, Harsch, Igor Alexander
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2021-03-01
Series:GMS Hygiene and Infection Control
Subjects:
Online Access:http://www.egms.de/static/en/journals/dgkh/2021-16/dgkh000382.shtml
id doaj-a26c288c7f564239838e34aef6fa3671
record_format Article
spelling doaj-a26c288c7f564239838e34aef6fa36712021-03-29T11:23:29ZdeuGerman Medical Science GMS Publishing HouseGMS Hygiene and Infection Control2196-52262021-03-0116Doc1110.3205/dgkh000382Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wardsEpstude, Jörg0Skiba, Marcin1Harsch, Igor Alexander2Department of Hospital Hygiene, Thuringia Clinic “Georgius Agricola”, Saalfeld/Saale, GermanyDepartment of Internal Medicine II, Thuringia Clinic “Georgius Agricola”, Saalfeld/Saale, GermanyDepartment of Internal Medicine II, Thuringia Clinic “Georgius Agricola”, Saalfeld/Saale, GermanyAim: The majority of patients hospitalized with COVID-19 are older individuals. Age and the comorbidities typically associated with it usually go hand in hand with a less favorable course of the disease. We were interested in the antibody response in this particular patient group as well as in the results of rapid antigen testing.Methods: In 30 elderly patients (>75 years), antibody titers (IgA and IgG) against COVID-19 were measured, and rapid antigen testing was determined about 3 weeks after the onset of symptoms of SARS- infection. The results were compared with those of a “high-risk” group consisting of “Covid-19” ward regular staff, as well as with “low-risk” staff consisting of members of the intensive care unit (ICU). The antibody titer against SARS-CoV-2 was determined by ELISA (EUROIMMUN™, PerkinElmer, Inc. Company); for rapid antigen testing, we used the SARS-CoV-2 Rapid Antigen test (Roche).Results: Our investigations demonstrate a robust antibody response in the majority of elderly, comorbid patients about three weeks after the onset of infection. At this timepoint, most of the results of rapid antigen testing were negative. Furthermore, in the group of employees of our clinic (“Covid-19” ward vs. the ICU staff), the prevalence of antibodies was very low and antigen testing was negative in the whole ICU group.Conclusion: Although frequently comorbid, elderly patients are capable of significantly increasing antibodies against COVID-19 about 3 weeks after the onset of infection. Since the viral load can be assumed to have been low at that point, rapid antigen testing was negative in most cases. In the test group of employees of our clinic (“Covid-19” ward vs. the ICU staff), the data demonstrate that – given adequate protective measures – the risk of infection is not higher in a “Covid-19” ward compared to other wards.http://www.egms.de/static/en/journals/dgkh/2021-16/dgkh000382.shtmlantibodiescovid-19sars-cov-2serologyrapid antigen testing
collection DOAJ
language deu
format Article
sources DOAJ
author Epstude, Jörg
Skiba, Marcin
Harsch, Igor Alexander
spellingShingle Epstude, Jörg
Skiba, Marcin
Harsch, Igor Alexander
Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards
GMS Hygiene and Infection Control
antibodies
covid-19
sars-cov-2
serology
rapid antigen testing
author_facet Epstude, Jörg
Skiba, Marcin
Harsch, Igor Alexander
author_sort Epstude, Jörg
title Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards
title_short Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards
title_full Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards
title_fullStr Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards
title_full_unstemmed Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and “Covid-19” wards
title_sort antibody titers and rapid antigen testing in elderly patients with sars-cov-2 pneumonia vs. staff of icu and “covid-19” wards
publisher German Medical Science GMS Publishing House
series GMS Hygiene and Infection Control
issn 2196-5226
publishDate 2021-03-01
description Aim: The majority of patients hospitalized with COVID-19 are older individuals. Age and the comorbidities typically associated with it usually go hand in hand with a less favorable course of the disease. We were interested in the antibody response in this particular patient group as well as in the results of rapid antigen testing.Methods: In 30 elderly patients (>75 years), antibody titers (IgA and IgG) against COVID-19 were measured, and rapid antigen testing was determined about 3 weeks after the onset of symptoms of SARS- infection. The results were compared with those of a “high-risk” group consisting of “Covid-19” ward regular staff, as well as with “low-risk” staff consisting of members of the intensive care unit (ICU). The antibody titer against SARS-CoV-2 was determined by ELISA (EUROIMMUN™, PerkinElmer, Inc. Company); for rapid antigen testing, we used the SARS-CoV-2 Rapid Antigen test (Roche).Results: Our investigations demonstrate a robust antibody response in the majority of elderly, comorbid patients about three weeks after the onset of infection. At this timepoint, most of the results of rapid antigen testing were negative. Furthermore, in the group of employees of our clinic (“Covid-19” ward vs. the ICU staff), the prevalence of antibodies was very low and antigen testing was negative in the whole ICU group.Conclusion: Although frequently comorbid, elderly patients are capable of significantly increasing antibodies against COVID-19 about 3 weeks after the onset of infection. Since the viral load can be assumed to have been low at that point, rapid antigen testing was negative in most cases. In the test group of employees of our clinic (“Covid-19” ward vs. the ICU staff), the data demonstrate that – given adequate protective measures – the risk of infection is not higher in a “Covid-19” ward compared to other wards.
topic antibodies
covid-19
sars-cov-2
serology
rapid antigen testing
url http://www.egms.de/static/en/journals/dgkh/2021-16/dgkh000382.shtml
work_keys_str_mv AT epstudejorg antibodytitersandrapidantigentestinginelderlypatientswithsarscov2pneumoniavsstaffoficuandcovid19wards
AT skibamarcin antibodytitersandrapidantigentestinginelderlypatientswithsarscov2pneumoniavsstaffoficuandcovid19wards
AT harschigoralexander antibodytitersandrapidantigentestinginelderlypatientswithsarscov2pneumoniavsstaffoficuandcovid19wards
_version_ 1724198777692094464